description
Leukotrienes (LTs) are biologically active molecules formed in response to inflammatory stimuli. They cause contraction of bronchial smooth muscles, stimulation of vascular permeability, and attraction and activation of leukocytes. LTs were discovered in 1938 and were termed the "slow release substance" (SRS) until their structures were determined in 1979 and they were then renamed to leukotrienes. LTs are derived from arachidonic acid through action by arachidonate 5-lipoxygenase (ALOX5). Cysteinyl leukotrienes (LTC4, LTD4, and LTE4) are generated as products derived from leukotriene A4 (LTA4). Eoxins are generated from leukotrienes (LTs) and resemble cysteinyl leukotrienes but have a different three-dimensional structure (Murphy & Gijon 2007, Hammarstrom 1983, MA.Claesson 2009, Vance & Vance 2008, Buczynski et al. 2009)

external resources
NCBI:1270089
REACTOME:R-HSA-2142691
PUBMED:6311078
PUBMED:19130894
PUBMED:17623009
PUBMED:19244215

genes
ALOX5 , ALOX5AP , ALOX15 , CYP4A11 , CYP4B1 , DPEP1 , GGT1 , GGT5 , LTA4H , CYP4F3 , LTC4S , ABCC1 , CYP4F2 , MAPKAPK2 , CYP4F8 , PTGR1 , CYP4F11 , DPEP2 , DPEP3 , GGTLC2 , CYP4F22 , CYP4A22 ,